Td Waterhouse Canada Inc. Liminal Bio Sciences Inc. Transaction History

Td Waterhouse Canada Inc.

  • $14.8 Trillion
  • Q2 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

Nov 13, 2023
SELL
$0.33 - $5.72 $20 - $354
-62 Closed
0 $0
Q2 2022

Nov 13, 2023
SELL
$0.44 - $0.97 $20 - $44
-46 Reduced 42.59%
62 $42,000
Q4 2021

Nov 13, 2023
BUY
$0.92 - $2.2 $99 - $237
108 New
108 $148,000

Others Institutions Holding LMNL

# of Institutions
2
Shares Held
234
Call Options Held
0
Put Options Held
0
View Full List

About Liminal BioSciences Inc.

LMNL Quotes by TradingView
  • Ticker LMNL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 31,042,600
  • Description
  • Liminal BioSciences Inc., a clinical-stage biopharmaceutical company, focuses on the development of novel small molecule drug therapeutics for inflammatory, fibrotic, and metabolic diseases in Canada and the United Kingdom. The company's lead product candidate is fezagepras (PBI-4050), which has been completed Phase I clinical trial for the trea...
More about LMNL
Track This Portfolio

Track Td Waterhouse Canada Inc. Portfolio

Follow Td Waterhouse Canada Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Td Waterhouse Canada Inc., based on Form 13F filings with the SEC.

News

Stay updated on Td Waterhouse Canada Inc. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email